| Element List | Explanation |
|---|---|
| Introduction | Al-Dawaa Medical Services Company announces the Board of Directors’ decision to distribute cash dividends to shareholders for the Third quarter of 2024 G. |
| Date of the board’s decision | 2025-02-03 Corresponding to 1446-08-04 |
| The Total amount distributed | 53,550,000 |
| Number of Shares Eligible for Dividends | 85,000,000 |
| Dividend per share | 0.63 |
| Percentage of Dividend to the Share Par Value (%) | 6.3 |
| Eligibility date | 2025-02-10 Corresponding to 1446-08-11 |
| Distribution Date | 2025-02-25 Corresponding to 1446-08-26 |
| The name of other official authorities and the details of their non-refusal to the recommendation or decision | NA |
| Additional Information | The company calls on its valued shareholders to quickly update their data and ensure that their bank account numbers are linked to their investment portfolios to ensure that their profits are deposited in their bank accounts on the distribution day. |
The company would like to draw the attention of non-resident investors in the Kingdom to the fact that the profits that the company will pay to them will be subject to a withholding tax of 5% when those profits are transferred or deposited in their bank accounts, in accordance with the provisions of the income tax system and its executive regulations.
Accordingly, the company emphasizes that non-resident investors who have tax exemptions on dividends issued by the Zakat, Tax and Customs Authority should contact the company within 5 calendar days from the due date and provide the company with documents supporting the tax exemption.
For inquiries and contact shareholder relations via
Email : shareholders.relations@al-dawaa.com.sa
cell 0538029822 or 0538556103
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.